Александра Владимировна Крутова
Александра Владимировна Крутова has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Iliya V. Zyabkin
Federal Scientific and Clinical Center for Children and Adolescents of the Federal Medical and Biological Agency; State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical-Biological Agency of Russia; Russian Medical Academy of Continuous Professional Education
3 shared publications - Valeriy A. Mukhortykh
Federal Research Centre of Nutrition, Biotechnology and Food Safety, 109240, Moscow, Russian Federation
3 shared publications Валерий Алексеевич Мухортых
ФГБУ «Федеральный научно-клинический центр детей и подростков» ФМБА России; ФГБУ ГНЦ «Федеральный медицинский биофизический центр им. А.И. Бурназяна» ФМБА России; ФГБУН «Федеральный исследовательский центр питания, биотехнологии и безопасности пищи
2 shared publications- Anatoly I. Khavkin
Research Clinical Institute of Childhood; Belgorod State National Research University
1 shared publication - Ekaterina V. Gur’eVa
Federal Scientific and Clinical Center for Children and Adolescents
1 shared publication - Elena P. Isaeva
Federal Scientific and Clinical Center for Children and Adolescents of the Federal Medical and Biological Agency; Burnasyan Federal Medical Biophysical Center
1 shared publication
Latest Publications
- Open Access
- 11 September 2026
- Published by Federal Medical Biological Agency in Extreme Medicine
- Vol. 28 (3) , 370-377
Risk factors for lipid metabolism disorders in underage athletes: A review
- 11 September 2026
- Published by Federal Medical Biological Agency in Extreme Medicine
- Vol. 28 (3) , 370-377
Open AccessRisk factors for lipid metabolism disorders in underage athletes: A review
- Open Access
- 22 January 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 6,p. 153-158
Pericarditis as a rare extraintestinal manifestation of ulcerative colitis in an adolescent
Inflammatory bowel disease (IBD) is a systemic disorder. Late diagnosis, inadequate therapy, and poor patient compliance lead to extraintestinal complications, worsening the course and prognosis of the underlying disease. The absence of specific manifestations of pericarditis, as well as the prominent symptoms of the underlying disease, can mask extraintestinal manifestations. A multidisciplinary approach helps prevent complications, achieve remission, and improve quality of life.
- 22 January 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 6,p. 153-158
Open AccessPericarditis as a rare extraintestinal manifestation of ulcerative colitis in an adolescent
Inflammatory bowel disease (IBD) is a systemic disorder. Late diagnosis, inadequate therapy, and poor patient compliance lead to extraintestinal complications, worsening the course and prognosis of the underlying disease. The absence of specific manifestations of pericarditis, as well as the prominent symptoms of the underlying disease, can mask extraintestinal manifestations. A multidisciplinary approach helps prevent complications, achieve remission, and improve quality of life.
- Open Access
- 29 April 2025
- Published by National Medical Research Center for Childrens Health in Russian Pediatric Journal
- Vol. 28 (2) , 141-147
Diagnostic features and management algorithm for children with dyslipidemia
Introduction. Lipid metabolism disorders play a key role in the development of cardiovascular diseases (CVD). Hyperlipidemia, which occurred in childhood, continues to progress over adulthood, contributing to the development of atherosclerosis. The lack of screening for the lipid profile, clinical manifestations and low alertness of pediatricians, lead to late detection of this pathology and minimize the possibility of using a set of preventive measures. The aim of the review is to determine the features of the diagnosis of lipid metabolism disorders for the development of an algorithm for managing children with dyslipidemia. The material for the analysis was scientific reports selected in the MedLine, Google Scholar, and PubMed databases from 1980 to 2025. An effective way to diagnose dyslipidemia is screening, which should be performed at the age of 9–11 years and 17–21 years. Dyslipidemia is diagnosed when changes in two lipid profiles are detected. It is necessary to exclude primary hypercholesterolemia, which has an unfavourable course. Risk factors for atherosclerosis and early vascular diseases are analyzed to determine management tactics. The main method of correcting lipid metabolism disorders in children is lifestyle modification. In the absence of an effect, statins are indicated, which are the drug of choice in all developed countries. The efficacy and safety of long-term use of statins in children has been demonstrated. Early diagnosis and timely initiation of treatment of hyperlipidemia in children play a significant role in reducing the risk of atherosclerotic diseases over the old age.
- 29 April 2025
- Published by National Medical Research Center for Childrens Health in Russian Pediatric Journal
- Vol. 28 (2) , 141-147
Open AccessDiagnostic features and management algorithm for children with dyslipidemia
Introduction. Lipid metabolism disorders play a key role in the development of cardiovascular diseases (CVD). Hyperlipidemia, which occurred in childhood, continues to progress over adulthood, contributing to the development of atherosclerosis. The lack of screening for the lipid profile, clinical manifestations and low alertness of pediatricians, lead to late detection of this pathology and minimize the possibility of using a set of preventive measures. The aim of the review is to determine the features of the diagnosis of lipid metabolism disorders for the development of an algorithm for managing children with dyslipidemia. The material for the analysis was scientific reports selected in the MedLine, Google Scholar, and PubMed databases from 1980 to 2025. An effective way to diagnose dyslipidemia is screening, which should be performed at the age of 9–11 years and 17–21 years. Dyslipidemia is diagnosed when changes in two lipid profiles are detected. It is necessary to exclude primary hypercholesterolemia, which has an unfavourable course. Risk factors for atherosclerosis and early vascular diseases are analyzed to determine management tactics. The main method of correcting lipid metabolism disorders in children is lifestyle modification. In the absence of an effect, statins are indicated, which are the drug of choice in all developed countries. The efficacy and safety of long-term use of statins in children has been demonstrated. Early diagnosis and timely initiation of treatment of hyperlipidemia in children play a significant role in reducing the risk of atherosclerotic diseases over the old age.
- Open Access
- 31 October 2023
- Published by National Medical Research Center for Childrens Health in Russian Pediatric Journal
- Vol. 26 (5) , 321-326
Functional state of the cardiovascular system in children after COVID-19
Introduction. The new coronavirus infection (COVID-19) in children often occurs in a mild, moderate, or asymptomatic. After experiencing COVID-19, some children, as well as adults, had persistent symptoms over more than 12 weeks and could not be explained by alternative diagnoses. These changes are called Post-acute COVID-19 Syndrome (PACS, post-COVID-19 syndrome or post-covid syndrome). Clinical manifestations of post-covid syndrome in children are very diverse, there are combinations of autonomic, psycho-emotional, cognitive and somatic disorders, including disorders of the cardiovascular system. Aim: analysis of changes in the functional state of the cardiovascular system in children in the post-covid period. Materials and methods. The study included one hundred thirty one child aged of 5 to 17 years 11 months 29 days (mean age 12 years [9.5; 15]). The observed children were divided into 2 groups: group 1 (main) — children who had a mild new coronavirus infection (n = 76). The comparison group consisted of children who did not have COVID-19, suffered from acute respiratory viral infections of unspecified etiology of a mild course (n = 55). All children were analyzed for medical history, underwent clinical examination, electrocardiographic examination (ECG), echocardiographic examination (ECHO-KG), 24-hour Holter ECG monitoring and 24-hour blood pressure (BP) monitoring. Results. Children who have had COVID-19 are significantly more often showed sinus tachycardia (p = 0.025), extrasystole (supraventricular, ventricular) (p = 0.046), atrioventricular blockade of the 2nd degree (p = 0.027) compared with children with ARVI. After undergoing COVID-19, in 19.7% of children an increase in blood pressure was detected, in 15.8% of children there was a significant decrease in blood pressure at night (p = 0.008). In 38.2% of children after COVID-19, there was a decrease in the activity of the parasympathetic division of the nervous system. Conclusion. Children who have had a new mild coronavirus infection were shown to undergo a clinical examination with a mandatory assessment of blood pressure, heart rate and an ECG 3 and 6 months after the illness.
- 31 October 2023
- Published by National Medical Research Center for Childrens Health in Russian Pediatric Journal
- Vol. 26 (5) , 321-326
Open AccessFunctional state of the cardiovascular system in children after COVID-19
Introduction. The new coronavirus infection (COVID-19) in children often occurs in a mild, moderate, or asymptomatic. After experiencing COVID-19, some children, as well as adults, had persistent symptoms over more than 12 weeks and could not be explained by alternative diagnoses. These changes are called Post-acute COVID-19 Syndrome (PACS, post-COVID-19 syndrome or post-covid syndrome). Clinical manifestations of post-covid syndrome in children are very diverse, there are combinations of autonomic, psycho-emotional, cognitive and somatic disorders, including disorders of the cardiovascular system. Aim: analysis of changes in the functional state of the cardiovascular system in children in the post-covid period. Materials and methods. The study included one hundred thirty one child aged of 5 to 17 years 11 months 29 days (mean age 12 years [9.5; 15]). The observed children were divided into 2 groups: group 1 (main) — children who had a mild new coronavirus infection (n = 76). The comparison group consisted of children who did not have COVID-19, suffered from acute respiratory viral infections of unspecified etiology of a mild course (n = 55). All children were analyzed for medical history, underwent clinical examination, electrocardiographic examination (ECG), echocardiographic examination (ECHO-KG), 24-hour Holter ECG monitoring and 24-hour blood pressure (BP) monitoring. Results. Children who have had COVID-19 are significantly more often showed sinus tachycardia (p = 0.025), extrasystole (supraventricular, ventricular) (p = 0.046), atrioventricular blockade of the 2nd degree (p = 0.027) compared with children with ARVI. After undergoing COVID-19, in 19.7% of children an increase in blood pressure was detected, in 15.8% of children there was a significant decrease in blood pressure at night (p = 0.008). In 38.2% of children after COVID-19, there was a decrease in the activity of the parasympathetic division of the nervous system. Conclusion. Children who have had a new mild coronavirus infection were shown to undergo a clinical examination with a mandatory assessment of blood pressure, heart rate and an ECG 3 and 6 months after the illness.